Warrants - Schedule of Warrants Outstanding and Exercisable (Details) - $ / shares |
9 Months Ended | |
|---|---|---|
Jul. 31, 2026 |
Oct. 31, 2025 |
|
| Schedule of Warrants Outstanding and Exercisable [Line Items] | ||
| Exercise of warrants price per share | $ 0.13 | |
| Warrant [Member] | ||
| Schedule of Warrants Outstanding and Exercisable [Line Items] | ||
| Exercise of warrants price per share | $ 0.13 | |
| Number Outstanding (in Shares) | 5,697,499 | 5,742,499 |
| Weighted Average Remaining Contractual Life (Years) | 2 years 3 months | |
| Weighted Average Exercise Price | $ 0.13 | $ 0.13 |
| X | ||||||||||
- Definition Represent the share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Represent the share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|